Nuwellis, Inc. Stock

Equities

NUWE

US67113Y4052

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 10:21:12 2024-05-13 am EDT 5-day change 1st Jan Change
0.245 USD -2.89% Intraday chart for Nuwellis, Inc. +45.09% -57.29%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 8.98M Sales 2025 * 10.32M Capitalization 3.84M
Net income 2024 * -10M Net income 2025 * -9M EV / Sales 2024 * 0.43 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.37 x
P/E ratio 2024 *
-0.27 x
P/E ratio 2025 *
-0.93 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day-8.09%
1 week+40.17%
Current month+63.41%
1 month-30.90%
3 months-46.90%
6 months-58.64%
Current year-56.57%
More quotes
1 week
0.21
Extreme 0.2118
0.36
1 month
0.13
Extreme 0.125
0.40
Current year
0.13
Extreme 0.125
0.86
1 year
0.13
Extreme 0.125
3.83
3 years
0.13
Extreme 0.125
539.00
5 years
0.13
Extreme 0.125
11 426.11
10 years
0.13
Extreme 0.125
1 000 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 19-05-06
Director of Finance/CFO 44 12-12-31
Chairman 75 12-08-31
Members of the board TitleAgeSince
Chairman 75 12-08-31
Director/Board Member 61 Oct. 31
Director/Board Member 74 11-08-02
More insiders
Date Price Change Volume
24-05-13 0.2481 -1.66% 553 435
24-05-10 0.2523 -8.09% 3,339,874
24-05-09 0.2745 +5.58% 21,816,314
24-05-08 0.26 -1.29% 9,701,879
24-05-07 0.2634 +54.04% 135,001,631

Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT

More quotes
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.2523
Average target price
-
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW